BackgroundDrug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening drug-related complication. There are no previous reports of pemetrexed plus cisplatin as first-line chemotherapy for non-small cell lung cancer. resulting in DIIHA. Case presentationIn this report. https://www.danddcollectiblers.shop/product-category/sweets-jar/
Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma
Internet 47 minutes ago mibnxkbs8b9qWeb Directory Categories
Web Directory Search
New Site Listings